Business Practice

View More Business Development Legal Policy Practice Regulatory

Business Development Legal Policy Practice Regulatory

Product Approvals and Launches

Stakeholder Summit

All Videos Insights Interviews Peer Exchange Podcasts Stakeholder Summit

Gastroenterology

Bone Health Dermatology Diabetes Gastroenterology Hematology Immunology Neurology Oncology Ophthalmology Rare Disease Respiratory Rheumatology

Conference Coverage

Conference Listing

Biosimilar Resources

Interactive Tools

Polls and Quizzes

WHEN CHOICE ARRIVES: Competition & Consequences

Authors Biosimilar Resources Interactive Tools Partners Polls and Quizzes Sponsored WHEN CHOICE ARRIVES: Competition & Consequences

Subscribe BIOSIMILAR APPROVALS

About
Editorial
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2024 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Editorial
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2024 MJH Life Sciences^™ and Center for Biosimilars®. All rights reserved.

Development

home

Biosimilars in the Pipeline and Disease Management

October 10th 2018

The Influence of Biosimilars in Cancer Care

October 10th 2018

Prescribing Biosimilars and Educating Patients and Physicians

October 10th 2018

Formulary Approval and Challenges for Payers

October 10th 2018

US and EU Biosimilar Pricing and Stakeholder Education

October 10th 2018

The Impact of Access to Biosimilars

October 10th 2018

Experience Prescribing Biosimilars Versus Biologics

October 10th 2018

Interchangeability and Postmarketing Pharmacovigilance of Biosimilars

October 10th 2018

Considerations for Approving Generics Versus Biosimilars

October 10th 2018

The Approval Process for Biosimilars

October 10th 2018

Advertisement

Advertisement